These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32450922)

  • 1. Detecting Subtle Cognitive Impairment in Multiple Sclerosis with the Montreal Cognitive Assessment.
    Charest K; Tremblay A; Langlois R; Roger É; Duquette P; Rouleau I
    Can J Neurol Sci; 2020 Sep; 47(5):620-626. PubMed ID: 32450922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montreal cognitive assessment for evaluating cognitive impairment in multiple sclerosis: a systematic review.
    Rosca EC; Simu M
    Acta Neurol Belg; 2020 Dec; 120(6):1307-1321. PubMed ID: 32996098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cambridge Neuropsychological Test Automated Battery (CANTAB) Versus the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) for the Assessment of Cognitive Function in Patients with Multiple Sclerosis.
    Talebi M; Majdi A; Kamari F; Sadigh-Eteghad S
    Mult Scler Relat Disord; 2020 Aug; 43():102172. PubMed ID: 32442887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Montreal Cognitive Assessment (MoCA) as a screening test for cognitive dysfunction in multiple sclerosis.
    Freitas S; Batista S; Afonso AC; Simões MR; de Sousa L; Cunha L; Santana I
    Appl Neuropsychol Adult; 2018; 25(1):57-70. PubMed ID: 27791389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Montreal Cognitive Assessment in a Greek sample of patients with multiple sclerosis: A validation study.
    Konstantopoulos K; Vogazianos P
    Appl Neuropsychol Adult; 2021; 28(1):48-52. PubMed ID: 30939943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Spanish-language version of the Montreal Cognitive Assessment as a screening test for cognitive impairment in multiple sclerosis.
    Gomez-Moreno SM; Cuadrado ML; Cruz-Orduña I; Martínez-Acebes EM; Gordo-Mañas R; Fernández-Pérez C; García-Ramos R
    Neurologia (Engl Ed); 2022; 37(9):726-734. PubMed ID: 34836843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity and sensitivity of Canadian normative data for the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) battery.
    Berard JA; Walker LAS
    Mult Scler Relat Disord; 2022 Jul; 63():103865. PubMed ID: 35580469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of the MoCA test as a screening instrument in multiple sclerosis.
    Dagenais E; Rouleau I; Demers M; Jobin C; Roger E; Chamelian L; Duquette P
    Can J Neurol Sci; 2013 May; 40(3):410-5. PubMed ID: 23603179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Quick Mild Cognitive Impairment (Qmci) screen to the Montreal Cognitive Assessment (MoCA) in an Australian geriatrics clinic.
    Clarnette R; O'Caoimh R; Antony DN; Svendrovski A; Molloy DW
    Int J Geriatr Psychiatry; 2017 Jun; 32(6):643-649. PubMed ID: 27427212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for cognitive impairment in older adults with hematological malignancies using the Montreal Cognitive Assessment and neuropsychological testing.
    Koll TT; Sheese AN; Semin J; Ernst W; High R; Wildes TM; Fisher A; Murman DL
    J Geriatr Oncol; 2020 Mar; 11(2):297-303. PubMed ID: 31831362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of the Montreal Cognitive Assessment (MoCA) screening tool to evaluate cognitive deficits in Lebanese in-patients with schizophrenia.
    Haddad C; Salameh P; Sacre H; Clément JP; Calvet B
    Asian J Psychiatr; 2022 Apr; 70():103029. PubMed ID: 35189473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for Mild Cognitive Impairment: Comparison of "MCI Specific" Screening Instruments.
    O'Caoimh R; Timmons S; Molloy DW
    J Alzheimers Dis; 2016; 51(2):619-29. PubMed ID: 26890758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital Screening for Cognitive Impairment - A Proof of Concept Study.
    Bloniecki V; Hagman G; Ryden M; Kivipelto M
    J Prev Alzheimers Dis; 2021; 8(2):127-134. PubMed ID: 33569558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for cognitive impairment with the Montreal Cognitive Assessment in Chinese patients with acute mild stroke and transient ischaemic attack: a validation study.
    Zuo L; Dong Y; Zhu R; Jin Z; Li Z; Wang Y; Zhao X; Sachdev P; Zhang W; Wang Y
    BMJ Open; 2016 Jul; 6(7):e011310. PubMed ID: 27406642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire.
    Benedict RH; Munschauer F; Linn R; Miller C; Murphy E; Foley F; Jacobs L
    Mult Scler; 2003 Feb; 9(1):95-101. PubMed ID: 12617275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-reported cognitive function mediates the relationship between employment status and cognitive functioning in persons with multiple sclerosis.
    Espiritu AI; Soliman Y; Blair M; Santo J; Casserly C; Racosta JM; Morrow SA
    Mult Scler Relat Disord; 2024 Jul; 87():105645. PubMed ID: 38761696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of the Italian multiple sclerosis neuropsychological screening questionnaire.
    Migliore S; Landi D; Proietti F; D'Aurizio G; Squitieri F; Mataluni G; Nicoletti CG; Curcio G; Marfia GA
    Neurol Sci; 2021 Nov; 42(11):4583-4589. PubMed ID: 33651198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) to functional, emotional, and neuropsychological outcomes.
    O'Brien A; Gaudino-Goering E; Shawaryn M; Komaroff E; Moore NB; DeLuca J
    Arch Clin Neuropsychol; 2007 Nov; 22(8):933-48. PubMed ID: 17851031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Italian validation of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) and the application of the Cognitive Impairment Index scoring procedure in MS patients.
    Argento O; Incerti CC; Quartuccio ME; Magistrale G; Francia A; Caltagirone C; Pisani V; Nocentini U
    Neurol Sci; 2018 Jul; 39(7):1237-1244. PubMed ID: 29704074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for brain fog: Is the montreal cognitive assessment an effective screening tool for neurocognitive complaints post-COVID-19?
    Lynch S; Ferrando SJ; Dornbush R; Shahar S; Smiley A; Klepacz L
    Gen Hosp Psychiatry; 2022; 78():80-86. PubMed ID: 35930974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.